Lucid Diagnostics

Aug 06, 2024

Lucid Diagnostics Announces Positive Data from ENVET-BE Clinical Utility Study of EsoGuard® Esophageal Precancer Testing

Aug 05, 2024

Lucid Diagnostics to Participate in Upcoming Investor Conferences

Jul 11, 2024

Lucid Diagnostics Launches New Corporate Website

May 09, 2024

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall

May 02, 2024

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing

Apr 08, 2024

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Mar 25, 2024

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results